Skip to main content

PAFIP-FAMILIAS: ESTUDIO DEL FUNCIONAMIENTO NEUROPSICOLOGICO Y VARIANTES GENETICAS ASOCIADAS EN FAMILIARES DE PACIENTES CON TRASTORNOS DEL ESPECTRO DE LA ESQUIZOFRENIA.

PI17/00221

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (CIBER)
Execution centre FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA (IDIVAL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A proxy measure of clinical insight in psychosis: an electronic health records-based validation study

  • López-Díaz, Álvaro
  • López-Morinigo, Javier-David
  • Ortiz-Garcia de la Foz, Victor
  • Marín-Mateo, Helena
  • Ortíz-Jiménez, María Dolores
  • Huarcaya-Victoria, Jeff David
  • Gutiérrez-Talavera, Gerardo
  • González-Blanch, César
  • Crespo-Facorro, Benedicto
  • Cuesta, Manuel Jesús
  • Ayesa-Arriola, Rosa
[Background] Insight assessment in psychosis remains challenging in practice-oriented research., [Aims] To develop and validate a proxy measure for insight based on information from electronic health records (EHR). For that purpose, we used data on the Scale to Assess Unawareness of Mental Disorder (SUMD) and data from EHR notes of patients in an early psychosis intervention programme (Programa de Atención a Fases Iniciales de Psicosis, Santander, Spain)., [Method] Junior and senior clinicians examined 134 clinical notes from 106 patients to explore criterion and content validity between SUMD and a clinician-rated proxy measure, using three SUMD items., [Results] In terms of criterion validity, SUMD scores correlated with the proxy (r = 0.61, P < 0.001), even after adjusting for the following confounders: type of psychotic disorder, clinical remission status and rater experience (r = 0.58, P < 0.001); and the proxy predicted good insight status (odds ratio 20.95, 95% CI 7.32–59.91, P < 0.001). Regarding content validity, the three main SUMD subscores correlated with the proxy (r = 0.55–0.60, P < 0.005). There were no significant differences in age, gender or other clinical variables, i.e. discriminant validity, and the proxy significantly correlated with validated psychometric instruments, i.e. external validity. Intraclass correlation coefficient (i.e. interrater reliability) was 0.88 (95% CI 0.59–1.00, P < 0.05)., [Conclusions] This SUMD-based proxy measure was shown to have good to excellent validity and reliability, which may offer a reliable and efficient alternative for assessing insight in real-world clinical practice, EHR-based research and management. Future studies should explore its applicability across different healthcare contexts and its potential for automation, using natural language-processing techniques., The PAFIP cohort-based projects were carried out at University Hospital Marqués de Valdecilla and Research Institute Valdecilla, and were supported by the Carlos III Health Institute (nos PI14/00639, PI17/00221 and PI20/00066). This work was supported by the Government of Navarra (grant no. 20/21) and by the Carlos III Health Institute (nos ICI21_00089, ICI19_00026 and FEDER Funds) from the Spanish Ministry of Economy and Competitivity (no. 19/1698)., Peer reviewed